consistent in nearly all available crystal structures except from the absence of the water molecules in one out of thirteen structures. From an analysis of the available electron densities of the SalL structures, it was however concluded that both L-Met and R243 S should be oriented as observed in FDAS. L-Met in PDB-ID 2Q6I was, therefore, replaced by L-Met from FDAS. Furthermore, the coordinates of R243 S were changed to those in the PDB-ID 2Q6L (a Y70T/G131S SalL mutant) which had a similar orientation as observed in FDAS. Finally, although the two water molecules were only present in one out of four PDB-files, it was evaluated from the electron densities that these were actually present in three out of four structures which indicated that they were important constituents of the active site. Thus, they were modeled into the 2Q6I structure from PDB-ID 2Q6O
(an Y70T SalL mutant). This modeled SalL structure will henceforth be denoted SalL*.
In addition to these two wt enzyme structures, four mutants were modeled for each enzyme:
T155A F /T128A S , W217F F /W190F S , Y266F F /Y239F S , and a double mutant W217F:Y266F F / W190F:Y239F S .
Initially, a substructure minimization was performed for all proteins (wt and mutants). Here, a 10 (FDAS) or 15 Å (SalL) shell was selected around L-Met for minimization, whereas the rest of the protein was constrained by a 50 Å shell surrounding the inner shell. Except these changes, default settings were applied. After minimization, all water molecules were removed and these "stripped" structures were used for the GRID calculation. The GRID calculation was performed in a box size of 30 Å centered around L-Met in the active site. Except from adjusting the grid point to 3 (NPLA = 3) and setting the number of hetero atoms to 19 (NETA = 19 = the number of atoms in Cl/FDA), default settings were used.
Furthermore, L-Met, S-ethyl-, S-propyl-, and S-butyl-L-Hcy were docked into four different structures:
FDAS and SalL* with both water molecules (subscribed AB for the two water molecules) and the same two protein structures without the two water molecules (subscribed NW for no water).
Site-directed mutagenesis, expression, and purification of SalL and FDAS
Based on molecular modeling, three amino acids were selected for a mutagenesis study (Table 1. 
1).
The mutants were produced from pAEM7 (for SalL) [1] and pFLA_HT (FDAS) [2] using the QuikChange Site-directed Mutagenesis kit (Agilent Technologies) and the primers listed in Table 1 .1. The mutations were verified by sequencing in both forward and reverse direction.
All proteins (wt and mutants) were expressed in BL21(DE3) cells. The cells were grown in LB medium with 50 µg/mL kanamycin at 37 °C until the OD 600 was 0.6-0.8 after which the temperature was adjusted to 16 °C. After 0.5-1 h of incubation at this temperature, protein expression was induced by 0.25 mM IPTG and the cells were left at 16 °C for o/n protein expression. Next day, cells were harvested at 6000 xg for 10 min. and resuspended in the following lysis buffer: 1X BugBuster Protein Extraction Reagent (Novagen, Merck), 100 mM phosphate buffer pH 6.8, 2 kU/mL chicken egg white lysozyme (Sigma), 25 U/mL benzonase (Novagen, Merck) and cOmplete Protease Inhibitor Cocktail (Roche) supplied in tablets according to manufactures protocol. The cells were lyses by gentle shaking at room temperature for 15-20 min. After lysis, insoluble cell debris was removed by centrifugation at 16 .000 xg for 20 min.
Initial expression experiments in small volumes indicated that five SalL mutants (Y239H-A) did not
express at all or at very low level. Attempts to express these mutants in higher yields were unsuccessful, and these were omitted from further analysis.
Although the T128A S mutant expressed in low yields it was attempted to purify it in larger yields, but as can be seen in Figure 1 .1.c (well 2) only very low yields were obtained, and it was difficult to estimate the purity. It was, however, attempted to test activity for this mutant.
Just prior to loading onto Ni Sepharose TM 6 Fast Flow resin, 50 mM imidazole and 150 mM NaCl were added to the lysate to reduce unspecific ionic interactions. Furthermore, 4 mM MgCl 2 was added to prevent Ni + stripping of the resin by the EDTA present in the protease inhibitor cocktail.
The supernatant was then loaded onto 1.5 mL resin (pr. 500 mL culture) by gravity flow. After extensive washing with 30 column volumes of wash buffer (50 mM imidazole, 20 mM phosphate, 150
mM NaCl and 10% glycerol), protein was eluted by a step-wise gradient using buffers similar to the wash buffer except from changing the imidazole concentrations (fractions no. in brackets): 4 mL 75 mM (1), 2 x 4 mL 100 mM (2,3), 2 mL 150 mM (4), 2 mL 200 mM (5), 2 x 2 mL 250 mM (6, 7) , and 5 x 2 mL 500 mM imidazole (8) (9) (10) (11) (12) FDAS and mutants expressed at higher levels than SalL and mutants which resulted in differences in purity from this first His-tag purification. FDAS and mutants were >95% pure from just this single purification step, whereas SalL and mutants were still impure ( To remove salt and imidazole, the pools of purified protein were concentrated and buffer exchanged into 20 mM phosphate buffer pH 6.8 and 10% glycerol using PD-10 columns. Wt and mutant SalL were then concentrated in this buffer using spin-filters to varying concentration ranging from 40-540 µM. Finally, glycerol was added to a final concentration of 50%. Wt and mutant FDAS, on the other hand, were first mixed with glycerol to 50% and then concentrated using the spin-filters. This was done to avoid precipitation of protein during ultrafiltration. Protein concentration was estimated by the Bradford protein assay using a protein standard consisting of BSA and lysozyme in a 1:1 mass ratio. All protein solutions were stored at -20 °C and they were all stable for at least 6 months.
pH dependence of FDAS
FDAS activity was assayed at five different pH values (4.7, 6.1, 7.0, 7.8, and 9.5) using saturating concentrations of L-Met (50 mM) and ClDA (200 μM). Different buffers were used: pH 4.7 was 50 mM sodium acetate buffer, pH 6.1-7.8 were 50 mM phosphate buffer, and pH 9.5 100 mM sodium carbonate buffer. As the L-Met solution contained NaOH, the pH of the buffers with L-Met were estimated and these estimated pH values are given above. 35 µM FDAS was mixed with 50 mM LMet and 200 µM ClDA in the respective buffers and incubated at 37 °C for 0, 10, 20, 30, and 40 min.
The reactions were quenched with an equal volume of 400 mM sodium formate buffer (pH 3) to eliminate further enzymatic activity and to increase the stability of SAM. Finally, the samples were analyzed by HPLC and the FDAS activity was calculated as the initial velocity of the reaction estimated from the area of SAM in the HPLC chromatogram.
Cloning, expression and purification of rat PRMT1
The gene for rat PRMT1 isoform 1 (rPRMT1v1, henceforth denoted rPRMT1) was isolated from a with 100 μg/mL ampicillin until OD 600nm was around 0.6-0.8. ZYM-5052r is a revised formula of ZYM-5052 described by Studier (2005) without lactose and with only half the concentration of glucose. [9] The temperature was then adjusted to 16 °C and after 1 h at this temperature expression was induced by 0.2 mM IPTG. After o/n expression, cells were harvested by centrifugation at 6000 xg and resuspended in lysis buffer (30 mL pr. 1.5 L culture): 40 mM phosphate buffer (pH 6.8), 300 mM NaCl, 0.1 mM MgCl 2 , 10% glycerol, 2 kU/mL lysozyme, 2.5 U/mL benzonase and EDTA-free cOmplete protease inhibitor cocktail tablet according to manufacturer's instructions. Cells were lyzed in Constant Cell Disruption Systems (Constant Systems Ltd) at 20 kpsi and the lysate was then cleared by centrifugation at 27.500 xg for 1 h.
The supernatant was supplemented with 20 mM imidazole, loaded onto pre-equilibrated Ni Since the first purification step did not give pure protein, a second purification was performed. The pool of protein from the first purification was diluted to an imidazole concentration of 50 mM and loaded onto 1.5 mL pre-equilibrated Ni Sepharose TM 6 Fast Flow resin. The resin was then washed with seven column volumes of wash buffer and elution was achieved with 1 mL fractions of increasing imidazole concentrations (fraction numbers in brackets): 2 x 75 mM (1,2), 2 x 100 mM (3,4), 2 x 150 mM (5.6), 6 x 200 mM (7-13) (Figure 1.3 ). The pool of pure rPRMT1 is shown in Figure   1 .3. The protein was concentrated by ultrafiltration to 60 µM.
Protein concentration was estimated by the absorbance at 280 nm and using an extinction coefficient of 54,320 M -1 cm -1 (calculated by the ProtParam Tool at Expasy.org) [10] .
Synthesis and purification of the RGG peptide
The RGG peptide (GGRGGFGGRGGFGGRGGFG-NH 2 , M monoisotopic = 1667.8137 g/mol) was synthesized on Applied Biosystems 433A Peptide Synthesizer using 1 g of Tentagel S RAM resin (RAPP Polymere GmbH) and 1 mmol F-moc protected amino acids (Applied Biosystems). After peptide synthesis, the peptide was cleaved off the resin by incubation in 2.5% triisopropylsilan, 7.5% MilliQ water and 90%
TFA for 2.5 h at rt. The peptide was then precipitated by ether and collected by centrifugation. Finally, the peptide was dissolved in water and its final concentration was estimated by N-detection on an Agilent HPLC system series 1200 coupled to an ANTEK 8060 Nitrogen Detector. 
were bought. All other L-Met analogs were synthesized according to the same protocol illustrated in Figure 1 .4. [11] The chemicals were purchased from Sigma-Aldrich or Chem-impex (L-homocystine) and were used without further purification. The specific protocols are given below. Furthermore, purification of selected analogs will be described. These analogs were applied in the coupled enzymatic assays and had to be purified to eliminate L-Met contaminations from L-homocystine.
For NMR, most products were insolvable in D 2 O but dissolved with the addition of NaOD. NMR spectra were recorded on a 300 MHz Varian Gemini or 300 MHz Varian Mercury spectrometer.
Chemical shifts are given in ppm () using dioxane as internal standards, and the coupling constants 
S-propyl-L-homocysteine (3c, (S)-2-amino-4-(propylthio)butanoic acid)
L-Homocystine (268 mg, 1 mmol) was dissolved in liquid ammonia (30 mL) at -78°C and sodium was added in small pieces until a dark blue color persisted for 15 min. NH 4 Cl was added until the blue color of the mixture faded. 1-Bromopropane (200 µL, 2.2 mmol) was added and the mixture was stirred at -78°C for 2h. The cooling bath was removed and the NH 3 was allowed to evaporate. The white solid was dissolved in water (50 mL) and extracted with ether (2 x 10 mL). The pH of the aqueous phase was adjusted to pH 6 with 4M HCl and 1M NaOH and the volume was reduced. The solution was left for crystallization to give the product as white crystals (125 mg, 0.71 mmol, 35%).
Crystallization of the motherliquid gave a second batch as white crystals (127 
S-allyl-L-homocysteine (3e, (S)-2-amino-4-(allylthio)butanoic acid)
L-Homocystine (268 mg, 1 mmol) was dissolved in liquid ammonia (30 mL) at -78°C and sodium was added in small pieces until a dark blue color persisted for 15 min. NH 4 Cl was added until the blue color of the mixture faded. Allyl bromide (186 µL, 2.2 mmol) was added and the mixture was stirred at -78°C for 2h. The cooling bath was removed and the NH 3 was allowed to evaporate. The white solid was dissolved in water (30 mL) and extracted with ether (2 x 10 mL). The pH of the aqueous phase was adjusted to pH 6 with 4M HCl and 1M NaOH and the volume was reduced. The solution was left for crystallization to give the product as white crystals (115 mg, 0.66 mmol, 33%).
Crystallization of the motherliquid gave a second batch as white crystals (146 
S-propargyl-L-homocysteine (3f, (S)-2-amino-4-(prop-2-yn-1-yl-thio)butanoic acid)
L-Homocystine (804 mg, 3 mmol) was dissolved in liquid ammonia (30 mL) at -78°C and sodium was added in small pieces until a dark blue color persisted for 20 min. NH 4 Cl was added until the blue color of the mixture faded. Propargyl bromide (80% in toluene, 710 µL, 2.2 mmol) was added and the mixture was stirred at -78°C for 2h. The cooling bath was removed and the NH 3 was allowed to evaporate. The white solid was dissolved in water (50 mL) and extracted with ether (2 x 10 mL). The pH of the aqueous phase was adjusted to pH 6 with 4M HCl and 1M NaOH and the volume was reduced. The solution was left for crystallization to give the product as reddish crystals (330 When dissolving this analog in 250 mM NaOH it was observed that a degradation product with a mass of +44 was formed. This mass difference is similar to that observed for Propargyl-SAM. [13] [14] [15] 
S-benzyl-L-homocysteine (3g, (S)-2-amino-4-(benzylthio)butanoic acid)
L-Homocystine (268 mg, 1 mmol) was dissolved in liquid ammonia (30 mL) at -78°C and sodium was added in small pieces until a dark blue color persisted for 15 min. NH 4 Cl was added until the blue color of the mixture faded. Benzyl chloride (253 µL, 2.2 mmol) was added and the mixture was stirred at -78°C for 2h. The cooling bath was removed and the NH 3 was allowed to evaporate. The white solid was dissolved in water (50 mL) and extracted with ether (2 x 10 mL). 
S-phenethyl-L-homocysteine (3h, (S)-2-amino-4-(phenethylthio)butanoic acid)
L-Homocystine (268 mg, 1 mmol) was dissolved in liquid ammonia (30 mL) at -78°C and sodium was added in small pieces until a dark blue color persisted for 15 min. NH 4 Cl was added until the blue color of the mixture faded. (2-Bromoethyl)benzene (298 µL, 2.2 mmol) was added and the mixture was stirred at -78°C for 2h. The cooling bath was removed and the NH 3 was allowed to evaporate.
The white solid was dissolved in water (50 mL) and extracted with ether (2 x 10 mL). The pH of the aqueous phase was adjusted to pH 6 with 4M HCl and 1M NaOH which resulted in heavy precipitation. The product was isolated as white crystals (353 
S-(2-amino-2-oxoethyl) -L-homocysteine (3i, (S)-2-amino-4-((2-amino-2-oxoethyl)thio)-butanoic acid)
L-Homocystine (804 mg, 3 mmol) was dissolved in liquid ammonia (40 mL) at -78°C and sodium was added in small pieces until a dark blue color persisted for 20 min. NH 4 Cl was added until the blue color of the mixture faded. 2-Chloroacetamide (617 mg, 6.6 mmol) was added and the mixture was stirred at -78°C for 2h. The cooling bath was removed and the NH 3 was allowed to evaporate. The white solid was dissolved in water (50 mL) and washed with ether (2x20 mL). The pH of the aqueous phase was adjusted to pH 6 with 4M HCl and 1M NaOH. 
Purification of selected L-Met analogs

S-ethyl-, S-propyl-, S-butyl-, and S-allyl-L-homocysteine
were purified in small amounts by analytical HPLC. The analogs were dissolved in 250 mM NaOH and purified using analytical HPLC with fractionation. They were purified according to the method described in section 1.1 using program I.
The pools of purified L-Met analog were freeze-dried and analyzed by LC MS confirming the presence the specific analogs.
Dissolvation of L-Met analogs
The 
Enzymatic synthesis of SAM and analogs
Based on the pH dependences of SalL [12] and FDAS (section 2.2) showing that these enzymes have maximum activities around neutral pH (pH 6-8), all enzymatic assays were performed in 100 mM phosphate buffer (pH 6.8). However, as L-Met and analogs were dissolved in 250 mM NaOH, the pH of the buffer changed after addition of L-Met and analogs. To all assays, the addition of L-Met or analog corresponded to 10% of the total reaction volume resulting in a final pH of 7.4.
The enzymatic assays were performed using 200 µM 5'-chloro-5'-deoxyadenosine (ClDA) and 15 mM L-Met and analogs, except for the benzyl and phenethyl analogs, which due to solubility issues could only be assessed at 1.5 mM. Initially, the reactions were performed using 3 µM SalL enzyme (wt or mutant) or 100 µM FDAS enzyme (wt or mutant), but due to reduced kinetics when using mutants and L-Met analogs, the enzyme concentrations were in some assays increased to 60 µM and 200 µM for SalL and FDAS enzymes, respectively.
In general, buffer, enzyme, and ClDA were mixed before the final addition of L-Met and analogs. This The initial velocity of the enzymatic reaction was determined from the ratio of the area of product against the total area of product and unreacted substrate (ClDA) at a time point at which the reaction did still proceed at a constant initial velocity. This velocity was similar to velocities determined by linear regression of the substrate consumption over time. In many cases, the reaction was very slow and the last time point at 5 h was assumed to be within the range of the initial velocity. For comparison, all initial velocities were divided with the enzyme concentration giving a relative initial velocity.
Control reactions without enzyme were also performed to verify that SAM analog formation was enzyme catalyzed.
All assays were performed in at least duplicate.
Enzymatic modification of the RGG peptide by rPRMT1 using SAM analogs
Initially, the activity of rPRMT1 was assessed using commercially available SAM. Here 2 µM rPRMT1 was incubated with 200 µM SAM and 10 µM RGG peptide in 100 mM phosphate buffer (pH 6.8) at 37 °C for 12 h after which the reaction was quenched with an equal volume of 400 mM sodium formate buffer (pH 3). The product was assessed by LC MS.
The in situ synthesis of SAM coupled to methylation of RGG was then probed by incubating 2 µM rPRMT1, 1 µM SalL, 200 µM ClDA, 15 mM L-Met, and 10 μM RGG peptide in phosphate buffer (pH 6.8) at 37 °C for 12 h. The reaction was quenched and analyzed as described above.
Modification of the RGG peptide with larger chemical groups than the methyl group from SAM was subsequently assessed in a similar manner using 15 mM L-Met analog (for all except the benzyl and phenethyl analog of which only 1.5 mM was used due to solubility issues), 200 µM ClDA and either
wt or W190A SalL in varying concentrations: S-ethyl-L-homocysteine -15 µM wt SalL; S-propyl-L-
homocysteine, S-allyl-L-homocysteine, S-benzyl-L-homocysteine -45 µM wt SalL; S-butyl-L-
homocysteine -45 µM W190A SalL. These coupled assays were performed as described for the coupled assay with L-Met and the product was analyzed by LC MS.
As a negative control, all above mentioned assays were also performed without addition of rPRMT1.
All assays were performed in duplicate.
Stability of SAM, ethyl-SAM, ClDA, adenosine, and SAH
To obtain a fresh solution of SAM and ethyl-SAM with the lowest amount of degradation as possible,
μM ClDA was incubated with 3 or 60 μM SalL and 15 mM L-Met or S-ethyl-L-homocysteine,
respectively, in 100 mM phosphate buffer (pH 7.4) for 30 minutes at 37 °C. This resulted in 100%
conversion.
The degradation of SAM and ethyl-SAM was then tested in two separated assays. In one assay, SAM or ethyl-SAM (100 µM) was incubated at 70 ˚C for 3 hours in the same phosphate buffer as above.
The degradation products were fractionated by HPLC and analyzed by LC MS. In the other assay, SAM or ethyl-SAM (100 µM) was incubated at 37 ˚C for 0, 0.5, 1, 1.5, 2, 3.5, and 5 h in either 100 mM phosphate buffer (pH 7.4) or 200 mM sodium formate buffer (pH 3.0). These buffer conditions are equivalent with the reaction buffer and the quenching buffer, respectively. Samples were mixed with an equal volume of 400 mM sodium formate buffer (pH 3) and stored at 4 °C until analysis by analytical HPLC. From the HPLC chromatogram, the areas of the peaks containing SAM or ethyl-SAM and their degradation products were estimated and used to calculate the concentration of each compound by assuming that all compounds have the same extinction coefficient. This assay was performed in duplicate.
The stabilities of ClDA, adenosine and the MTase product SAH were explored in a similar assay as the latter described above.
Supporting results
Molecular modeling and rational design of mutants
In 12 out of the 13 available FDAS crystal structures two water molecules (A and B) were observed in a cavity into which the L-Met analogs were assumed to propagate (henceforth denoted water cavity).
These were also observed in three of the four SalL structures. If these water molecules could not be 
pH dependence of FDAS
In Lipson et al it was shown that SalL is most active in the neutral pH interval from 7-8. 12 The pH dependence of FDAS was assayed in a similar manner, and it was observed that FDAS had maximal activity at slightly lower pH values, pH 5 to 7 (Figure 2.3) . However, to ease the performance of the assays it was decided to used pH 7.4 for both FDAS and SalL although this would lead to approximately 10% loss of FDAS activity. 
The relative initial velocities of SAM and analog formation for all SalL and FDAS enzymes are shown in Table 2.1 and Table 2 In addition, as degradation of most SAM analogs was observed during the incubation time, the area of product used to calculate the initial velocity was estimated as a summation of the area of SAM analog (both diastereomers) and the degradation products (see section 2.4).
Using L-Met, the activity of wt SalL (v 0 = 4,930 ± 230 nM/min) was approximately 500 fold higher than the activity of wt FDAS (v 0 = 10 ± 2 nM/min). These activities were for 1 μM enzyme. This difference in activity was in the same range as reported earlier with k cat values of 12 min. and FDA. [1, 5] This suggested that the applied concentration of L-Met was adequately above K M resulting in maximal activities. Assuming that saturating conditions were used for L-Met, the k cat for SalL and FDAS could be estimated to 4.9 and 0.01 min.
-1 which, although slightly different, were in the range of those reported in literature. 
Degradation of SAM and ethyl-SAM
It is well known that SAM is degraded by three mechanisms: I) Intermolecular nucleophilic attack by the oxygen of the carboxylate group of the L-Met moiety of SAM at the C γ next to the sulfonium center forming 5'-methylthioadenosine (MTA) and homoserine lactone, II) Hydrolysis into adenine and S-pentonylmethionine and III) Racemization at the sulfonium center. Whereas the rate of mechanism I and II increases with increasing pH values, the rate of racemization is independent of pH. However, due to the pH dependence of mechanism I and II, these cease below pH 1.5 and 6, respectively. [16] [17] [18] To probe the stability of SAM and ethyl-SAM, they were prepared fresh as described in section 1.9.
Chromatograms of the newly prepared samples are shown in Figure 2 .8 to visualize the homogeneous samples of the intact molecules. To obtain fully degraded samples, both compounds were exposed to 70 °C in a neutral pH buffer. As can be seen in Figure 2 .8, both SAM and ethyl-SAM were completely degraded into two detectable molecules (using absorbance at 260 nm). LC MS analysis of the degradation products verified the breakdown of SAM into methylthioadenosine (MTA) and adenine which was consistent with the reported breakdown mechanisms (Figure 2.9) . [16] [17] [18] For ethyl-SAM, the same degradation pattern was observed (Figure 2.9 ). Here, ethyl-SAM was degraded into ethylthioadenosine (EtTA) and adenine. In the LC MS spectrum of MTA as well as EtTA, adenine was also detected. However, as adenine and MTA / EtTA were completely separated during the analytical HPLC, this adenine peak was assumed to originate from the degradation of MTA and EtTA during the LC MS run. As noted in section 2.3, this degradation was also seen for SAM and analogs. To obtain information about the rate of the degradation under the conditions employed in the enzyme assays, SAM and ethyl-SAM were again prepared fresh from ClDA and L-Met or S-ethyl-Lhomocysteine, respectively. In this assay, however, the stability was tested at 37 °C in the reaction buffer (pH 7.4) and in the quenching buffer (pH 3.0). Samples were taken with regular time intervals and degradation products were detected by analytical HPLC (Figure 2 .10). For SAM, the rate of racemization could not be accessed as the diastereomers were not properly separated by analytical HPLC using the described conditions. The estimated concentration of SAM was therefore the total concentration of both diastereomers. For SAM, the total degradation (excluding racemization) within 5 hours of incubation was lowered from 15.3% at pH 7.4 to 3.5% at pH 3.0 due to a 50% reduction in MTA degradation and a complete elimination of adenine degradation.
For ethyl-SAM the same trends were seen. Here the total degradation within five hours of incubation was reduced from 32.4% at pH 7.4 to 21.6% at pH 3.0 (including racemization). The increase in the percentage of total degradation was due to the fact that for ethyl-SAM the racemization could be assessed and the racemization accounts for approximately 13% at pH 7.4 and 19% at pH 3.0. The pH variance was believed to be the result of an increased degradation of both the inactive and active diastereomers at pH 7.4. If SAM racemized with the same rate as observed for ethyl-SAM the degradation pattern was similar for SAM and ethyl-SAM. These data were consistent with a study of Hoffmann (1986) except from the estimated relative rate of racemization. [16] Here the rate of racemization was 40% of that of adenine formation at pH 7.5, whereas in this study the rate of racemization was estimated to 120% of the rate of adenine formation. Possibly, the rate of racemization was overestimated due to overlapping peaks in the HPLC chromatogram as this complicated the exact calculation of the areas of each diastereomer.
The same assays were performed for ClDA, adenosine, and SAH. However, for all of these compounds no degradation was observed at either pH 3.0 or 7.4 (data not shown). This confirmed that the inherent instability of SAM and analogs owed to the presence of the positively charged sulfonium ion which was consistent with a study by Borchardt.
[17]
Enzymatic modification of the RGG peptide by rPRMT1
Application of the SAM analogs in a coupled assay was then probed. Initially, two positive controls were performed -one in which the activity of rPRMT1 was tested by incubation with SAM and one in which the enzymatic SAM formation was coupled to the methylation of the RGG peptide. For both assays, a symmetrical peak of fully hexa-methylated RGG peptide was observed by LC MS indicating that the rPRMT1 was indeed active and that the coupled assay was successful ( ethyl, allyl, and benzyl were accepted as substrates. Thus, there was a clear difference in the activity of the allyl and propyl analog although they had similar sizes. As both SAM analogs were produced in similar rates, this indicated that the double bond beta to the sulfur accelerated the reaction which was consistent with a study of DNA MTases. [19] Concerning the benzyl analog of L-Met, modified RGG peptide was observed in small but reproducible amounts (Figure 2.15 ).
For most of the LC MS chromatograms shown here, there were some minor impurities eluting at similar retention times as for un-and modified RGG peptide. These originated from the LC MS instruments and enzyme solutions (data not shown).
Please note, that the MS software by default numbers the peak with highest occurrence. This meant that for some MS peaks the numbered peak was not the monoisotopic ion. However, for all peaks which were assigned as double, triple or tetra-protonated peptides, the respective peaks were checked manually for the monoisotopic mass and change. 
